Literature DB >> 13673574

Darenthin: hypotensive agent of new type.

A L BOURA, A F GREEN, A McCOUBREY, D R LAURENCE, R MOULTON, M L ROSENHEIM.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; SYMPATHOLYTICS/therapeutic use

Mesh:

Substances:

Year:  1959        PMID: 13673574

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  History of research into hypertension.

Authors:  A L Boura
Journal:  J R Soc Med       Date:  1992-08       Impact factor: 5.344

2.  EFFECTS OF HYPERCAPNIA ON THE VASCULAR RESISTANCE OF THE DOG'S HIND LIMB.

Authors:  J LITWIN; A H DIL; D M AVIADO
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1963-08-09

3.  Guanethidine in hypertension. Experiences in an East African hospital.

Authors:  R P TURNER
Journal:  Br Med J       Date:  1962-03-31

4.  Bretylium tosylate in treatment of severe hypertension.

Authors:  K SOMERS
Journal:  Br Med J       Date:  1962-03-31

5.  Vasodilator drugs for peripheral vascular disease.

Authors:  J F GOODWIN
Journal:  Br Med J       Date:  1960-06-11

6.  Supersensitivity of salivary glands following treatment with bretylium or guanethidine.

Authors:  N EMMELIN; J ENGSTROM
Journal:  Br J Pharmacol Chemother       Date:  1961-06

7.  Treatment of severe hypertension with bretylium tosylate.

Authors:  E F MONTUSCHI; H E PEARSON; L L WILSON
Journal:  Br Med J       Date:  1960-10-22

8.  Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate.

Authors:  C P LOWTHER; R W TURNER
Journal:  Br Med J       Date:  1960-10-08

9.  Sympathetic postganglionic cholinergic fibres.

Authors:  J H BURN; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1960-03

10.  Clinical experience with bretylium tosylate.

Authors:  J A LEWIS
Journal:  Can Med Assoc J       Date:  1960-04-23       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.